All community pharmacist articles
-
PHE/DH/DWP guidelinePHE influenza immunisation guideline
This Guidelines summary covers key points for administering influenza immunisation, and who should receive it.
-
NHS guideline
NHS guidance on NSAIDs in COVID-19
This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.
-
PHE/DH/DWP guideline
PHE guideline on management of exposure to COVID-19
This summary provides guidance on the management of staff and patients in health and social care settings according to exposures, symptoms, and test results.
-
Independent professional body guideline
FSRH UKMEC contraception guideline
A summary of the FSRH UKMEC guidance on the safety of contraceptive methods, which is set out in clear and concise tables.
-
Independent professional body guideline
ROS guideline: vitamin D and bone health in children
A clear summary on the management of vitamin D deficiency in children and young people.
-
Independent professional body guideline
PCDS management of acne guideline
A concise summary of the Primary Care Dermatology Society's guideline on the treatment of acne vulgaris.
-
Independent professional body guideline
PCDS atopic eczema guideline
An overview of the management of atopic eczema. Covers taking a clinical history, step-by-step treatment, and includes an eczema management plan.
-
PHE/DH/DWP guideline
PHE pneumococcal vaccination guideline (Green Book chapter 25)
A succinct summary of Public Health England’s Green Book chapter 25 pneumococcal vaccination programme
-
Independent professional body guideline
Recognition and management of sepsis in general practice
This Guidelines summary combines recommendations from The UK Sepsis Trust to give guidance on the recognition and management of sepsis in adults, children, and young people over 12 years of age
-
NHS guideline
NHS England COVID-19 community pharmacy guideline
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. This guidance is correct at the time of publishing. The Guidelines team review the information daily and update as ...
-
Independent professional body guideline
Recommended actions after incorrect use of combined hormonal contraception
This Guidelines summary guides management for when a woman has made a mistake using combined oral contraceptive pills, combined vaginal ring, and combined transdermal patch.
-
NICE guideline
NICE CKS—teething
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Please refer to the full guideline for the complete set of recommendations.
-
NICE guideline
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
-
Independent professional body guideline
SPS advice to chief pharmacists: assessing the quality of cannabis-based products for medicinal use (CBPM) and cannabis-based food supplements available in the UK
Summary This document provides an overview of the quality assurance issues to consider when procuring and supplying cannabis products for medicinal use. 1. With the exception of Sativex, cannabis-based products available in the UK fall into 3 categories: Unlicensed cannabis-based products for medicinal ...
-
NICE guideline
NICE CKS candida—female genital
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting.
-
NICE guideline
NICE CKS—diarrhoea
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. For community pharmacists, the referral section implies primary care referral prior to secondary care referral. Please see the full guideline ...
-
NICE guideline
NICE CKS allergic rhinitis
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Please refer to the full guideline for the complete set of recommendations. What is it? Allergic rhinitis is an ...
-
NICE guideline
NICE CKS—earwax
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Areas covered include: diagnosis, management, and referral. Please refer to the full guideline for the complete set of recommendations. ...
-
NICE guideline
NICE CKS—head lice
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Areas covered include: treatment and management, advantages and disadvantages of treatment options, information and advice for those with the condition. Please refer to ...
-
NICE guideline
NICE CKS—warts and verrucae
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Areas covered include: an overview of the condition, differential diagnoses, advice for those with the condition, and treatment. Please refer to the full ...
